TABLE 2.
Comparison of different SARS-CoV-2 nucleic acid detection methods.
| Methods | Sample types | Absolute quantification | Sophisticated instrument | Time | LOD | Target gene | Advantages | Disadvantages |
| Sequencing | Nasopharyngeal swab | N | Y | 2–3 days | — | — | More precise, genomic profiling, new mutations detection | Time-consuming, expensive, specialized operators |
| RT-PCR | Nasopharyngeal swab, sputum, bronchoalveolar lavage fluid, stool | Y | Y | 70–120 min | 100 copies/ml | ORF1ab, N | Mature technology, complete supporting reagents, absolute quantification, low cost | Thermal cycling, specialized operators, time-consuming |
| RT-LAMP | Nasopharyngeal swab, sputum, stool | N | N | 30–60 min | 1 copies/μl | ORF1ab, N | Isothermal, simple, rapid, highly sensitive | Non-specific amplification, too many primers, ladder band |
| RT-RPA | Nasopharyngeal swab, sputum, stool | N | N | 20–40 min | 0.25–2.5 copies/μl | N | Isothermal, simple, rapid, highly sensitive | Non-specific amplification, no primer design software, too many enzymes in system |
| CRISPR-based assay | Nasopharyngeal swab, bronchoalveolar lavage fluid | N | N | 30–60 min | 0.9–10 copies/μl | ORF1ab, N, E | Isothermal, amplify the signal, easy to combine with isothermal amplification | Immature technology, reaction system to be optimized |
| Biosensors and microfluidics | Nasopharyngeal swab, sputum, bronchoalveolar lavage fluid | N | N | 60 min | 0.5 copies/μl | N, M | Miniaturization, simple, real-time detection | Sensitive to surrounding environment, complex design, high cost |